Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials
Kimball, Alexa B, Jemec, Gregor B E, Alavi, Afsaneh, Reguiai, Ziad, Gottlieb, Alice B, Bechara, Falk G, Paul, Carle, Giamarellos Bourboulis, Evangelos J, Villani, Axel P, Schwinn, Andreas, Ruëff, Franziska, Pillay Ramaya, Larisha, Reich, Adam, Lobo, Ines, Sinclair, Rodney, Passeron, Thierry, Martorell, Antonio, Mendes-Bastos, Pedro, Kokolakis, Georgios, Becherel, Pierre-Andre, Wozniak, Magdalena B, Martinez, Angela Llobet, Wei, Xiaoling, Uhlmann, Lorenz, Passera, Anna, Keefe, Deborah, Martin, Ruvie, Field, Clarice, Chen, Li, Vandemeulebroecke, Marc, Ravichandran, Shoba, Muscianisi, Elisa
Published in The Lancet (British edition) (04.03.2023)
Published in The Lancet (British edition) (04.03.2023)
Get full text
Journal Article
Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19
Evering, Teresa H, Chew, Kara W, Giganti, Mark J, Moser, Carlee, Pinilla, Mauricio, Wohl, David Alain, Currier, Judith S, Eron, Joseph J, Javan, Arzhang Cyrus, Bender Ignacio, Rachel, Margolis, David, Zhu, Qing, Ma, Ji, Zhong, Lijie, Yan, Li, D'Andrea Nores, Ulises, Hoover, Keila, Mocherla, Bharat, Choudhary, Manish C, Deo, Rinki, Ritz, Justin, Fischer, William A, Fletcher, Courtney V, Li, Jonathan Z, Hughes, Michael D, Smith, Davey, Daar, Eric S
Published in Annals of internal medicine (01.05.2023)
Published in Annals of internal medicine (01.05.2023)
Get more information
Journal Article
Efficacy and Safety of Adintrevimab (ADG20) for the Treatment of High-Risk Ambulatory Patients With Mild or Moderate Coronavirus Disease 2019: Results From a Phase 2/3, Randomized, Placebo-Controlled Trial (STAMP) Conducted During Delta Predominance and Early Emergence of Omicron
Ison, Michael G, Popejoy, Myra, Evgeniev, Nikolay, Tzekova, Maria, Mahoney, Kathryn, Betancourt, Natalia, Li, Yong, Gupta, Deepali, Narayan, Kristin, Hershberger, Ellie, Connolly, Lynn E, Yalcin, Ilker, Das, Anita F, Genge, John, Smith, Michelle, Campanaro, Ed, Hawn, Pamela, Schmidt, Pete
Published in Open forum infectious diseases (01.06.2023)
Published in Open forum infectious diseases (01.06.2023)
Get full text
Journal Article
Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial
Ritz, Justin, Li, Jonathan Z., Wohl, David, Giganti, Mark, Patel, Nilam, Colsh, Kelly, Evering, Teresa H., Ignacio, Rachel Bender, Jilg, Nikolaus, Perelson, Alan, Taiwo, Babafemi, Gottesman, Joan, Newell, Matthew, Pedersen, Susan, Gapara, Morgan, Margolis, David, Nuñez, Sebastian, Papasidero, Marcelo, Wehbe, Luis, Voena, Felicitas Fernandez, Lopez, Amaru, Huhn, Virginia, Dieser, Pablo, Mussi, Marisa, de Carvalho Santana, Rodrigo, Tiraboschi Bárbaro, Adriana Aparecida, Santos, Breno, Cardoso, Sandra Wagner, Diniz Ribeiro, Maria Pia, Vasconcellos, Eduardo, Faleiro Ferreira, Flávia Gomes, Bohorquez Lopez, Victor Casildo, Coetzer, Thomas, Madlala, Penelope, Petrick, Frederick, Mbali, Rose, Zwane, Zinhle, Chiperera, Tendai, Mohapi, Lerato, Singh, Usha, McHarry, Kirsten, Snyman, Elizma, Adonis, Tania, Sein, Ni Ni, Mitha, Ismail, Lummus, Christie, Kim, Andrew, Kao, Wei-Hsin, Pfeffer, Michael M., Arnold, Melanie, Karpf, Cinzia, Yawetz, Sigal, Keenan, Cheryl, Milstone, Aaron, Berardi, Jonathan, Arar, Celine, Gomez-Martinez, Marissa, Focil, Augusto, Rosas, Griselda, Bukhman, Eugene, Farah, Humam, Kingsley, Jeffrey, Herman, Craig, Leon, Ramon, Nikolov, Boris, Jagizarov, Zarema, Becker, Becky, Maldonado, Valarie, Veltman, Jennifer, Pullman, John, Johnson, Misty, Hecker, Michelle, Wernick, Arthur, Ruiz, Karelia, Harber, Heather, Cicarella, Robyn, Pulliam, Sallie D., Socorro, Estefania, Neytman, Gene, Aziz, Mariam, Swiatek, Joan, Hoover, Susan E., Weston, Patrick, Sullivano, Jennifer, Clemency, Brian, Khodabakhshian, Aleen, Fortier, Samantha, Rathore, Mobeen, Mahmoudi, Saniyyah, Spikes, Leslie, Hall, Chase, Loftis, Amy James, Short, William, Mendez, Luis M., Jonsson, Chris, Nakatani, Lisa, Williamson, Derrick, Atriss, Hisham, Caloura, Matthew, Presti, Rachel
Published in EClinicalMedicine (01.09.2024)
Published in EClinicalMedicine (01.09.2024)
Get full text
Journal Article
Efficacy and Safety of Adintrevimab (ADG20) for the Treatment of High-Risk Ambulatory Patients With Mild or Moderate COVID-19: Results From a Phase 2/3, Randomized, Placebo-Controlled Trial (STAMP) Conducted During Delta Predominance and Early Emergence of Omicron
Ison, Michael G, Popejoy, Myra, Evgeniev, Nikolay, Tzekova, Maria, Mahoney, Kathryn, Betancourt, Natalia, Li, Yong, Gupta, Deepali, Narayan, Kristin, Hershberger, Ellie, Connolly, Lynn E, Yalcin, Ilker, Das, Anita F, Genge, John, Smith, Michelle, Campanaro, Ed, Hawn, Pamela, Schmidt, Pete, Muniz, Heloísa Costa Ravagnani, Tzekova, Maria, Palaveev, Kiril, Tsenov, Vasil, Pekova, Lilia, Hadzhieva, Antoaneta, Mitreva, Roza, Nikolaev, Nikolay, Gyuzeleva, Elena, Kornmann, Marc Oliver, Schmidt, Olaf, Poulakou, Garyfalia, Milionis, Charalampos, Kofteridis, Diamantis, Dimopoulos, Meletios-Athanasios, Skopelitis, Ilias, Kotanidou, Anastasia, Tsiodras, Sotirios, Kania, Grzegorz, Grenik, Dagmara, Zajac, Tomasz, Streinu-Cercel, Anca, Pillay-Ramaya, Larisha, Mookadam, Mohamed, Mohapi, Lerato, Geldenhuys, Johan George, Vahed, Yacoob, Holmgren, Chantelle, Mekebeb-Reuter, Martha, Brumskine, William, De Jong, Douwe, Joseph, Natasha, McHarry, Kirsten, Wadvalla, Shahid, Kobrynska, Olena, Kireyev, Igor, Lebed, Kyrylo, Logoida, Pavlo, Barna, Olga, Gyrina, Olga, Gundertaylo, Bogdan, Rodionova, Viktoriia
Published in Open forum infectious diseases (24.05.2023)
Published in Open forum infectious diseases (24.05.2023)
Get full text
Journal Article